Dr. Silver, a Professor of Medicine at Weill Medical College of Cornell University and the Director at Weill Cornell of the Center for the Study of Leukemia and Myeloproliferative Diseases, has long been in the forefront of clinical cancer research. In 1958, only five years out of medical school, he was one of the authors of a groundbreaking paper reporting the first significant success in achieving remissions in acute leukemia. Hundreds of research articles and thousands of patients later, he was a principal investigator in the world trials of the highly effective new anti-leukemia pill Gleevec. Currently he oversees an international trial of the new drug against polycythemia vera, a life-threatening disease characterized by overproduction of red blood cells (continue reading....)
Medical Imaging, Helpful or Harmful or Both? (2010)
An Aging Patient Population and Two Few Cancer Specialists (2009)